SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-070141
Filing Date
2019-03-11
Accepted
2019-03-11 08:45:33
Documents
8
Period of Report
2019-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695253d8k.htm 8-K 26394
2 EX-1.1 d695253dex11.htm EX-1.1 163054
3 EX-4.1 d695253dex41.htm EX-4.1 98591
4 EX-4.2 d695253dex42.htm EX-4.2 101554
5 EX-5.1 d695253dex51.htm EX-5.1 10519
6 EX-10.1 d695253dex101.htm EX-10.1 150364
7 EX-99.1 d695253dex991.htm EX-99.1 24590
8 GRAPHIC g695253g59f32.jpg GRAPHIC 14715
  Complete submission text file 0001193125-19-070141.txt   596835
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 19671025
SIC: 2834 Pharmaceutical Preparations